Literature DB >> 34855652

Paradoxical increase in ambulatory SBP in coarctation of aorta a compared to essential hypertension.

Alexander C Egbe1, William R Miranda, Likhita Shaik, Renuka Reddy Katta, Ahmed Goda Sakr, Janaki Devara, Heidi M Connolly.   

Abstract

BACKGROUND: The relationship between office vs. ambulatory blood pressure (BP) indices are well-studied in patients with essential hypertension and based on these data, it is known that the average 24-h ambulatory BP is typically lower than office BP. However, emerging data show that office SBP underestimates arterial afterload in patients with coarctation of aorta (COA), and a minimal increase in stroke volume during low-intensity exercise results in an exaggerated rise in SBP as compared to those with essential hypertension. We hypothesized that COA patients will have higher ambulatory SBP and a higher prevalence of masked hypertension compared to patients with essential hypertension.
METHODS: Case-control study of 118 COA patients and 118 patients with essential hypertension matched by age, sex, BMI and office SBP.
RESULTS: Although both groups had similar office SBP (132 ± 17 mmHg) by design, the COA group had paradoxical increases in 24-h ambulatory SBP (135 ± 14 vs. 126 ± 13; P < 0.001) and daytime ambulatory SBP (142 ± 16 vs. 130 ± 13; P < 0.001), and less nocturnal dipping (-3 ± 5 vs. -9 ± 4; P < 0.001). The COA group also had a higher prevalence of masked hypertension [36 (31%) vs 14 (12%); P < 0.001), and worse arterial function indices.
CONCLUSION: These findings underscore the potential limitations of relying on office SBP for screening/monitoring of hypertension in COA and potential pitfalls in extrapolating essential hypertension guidelines recommendations to the treatment of COA. It also provides the rationale for further studies to determine if pharmacologic BP interventions guided by ambulatory BP data will improve clinical outcomes in the COA population.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34855652      PMCID: PMC8897210          DOI: 10.1097/MBP.0000000000000573

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  23 in total

1.  Accuracy of the SpaceLabs Medical 90217 ambulatory blood pressure monitor.

Authors: 
Journal:  Blood Press Monit       Date:  1998-10       Impact factor: 1.444

2.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

Authors:  Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

3.  Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function.

Authors:  G Di Salvo; B Castaldi; L Baldini; S Gala; F del Gaizo; A D'Andrea; G Limongelli; A F D'Aiello; G Scognamiglio; B Sarubbi; G Pacileo; M G Russo; R Calabrò
Journal:  J Hum Hypertens       Date:  2011-01-13       Impact factor: 3.012

4.  2018 ESC/ESH Guidelines for the management of arterial hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 29.983

Review 5.  Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review.

Authors:  Julio A Chirinos; Patrick Segers; Timothy Hughes; Raymond Townsend
Journal:  J Am Coll Cardiol       Date:  2019-09-03       Impact factor: 24.094

6.  Mild Coarctation of Aorta is an Independent Risk Factor for Exercise-Induced Hypertension.

Authors:  Alexander C Egbe; Thomas G Allison; Naser M Ammash
Journal:  Hypertension       Date:  2019-10-21       Impact factor: 10.190

7.  Coarctation Long-term Assessment (COALA): significance of arterial hypertension in a cohort of 404 patients up to 27 years after surgical repair of isolated coarctation of the aorta, even in the absence of restenosis and prosthetic material.

Authors:  Alfred Hager; Simone Kanz; Harald Kaemmerer; Christian Schreiber; John Hess
Journal:  J Thorac Cardiovasc Surg       Date:  2007-09       Impact factor: 5.209

8.  European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

Authors:  Gianfranco Parati; George Stergiou; Eoin O'Brien; Roland Asmar; Lawrence Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2014-07       Impact factor: 4.844

9.  Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies.

Authors:  Peter C Austin
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

10.  Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?

Authors:  D Edmund Anstey; Paul Muntner; Natalie A Bello; Daniel N Pugliese; Yuichiro Yano; Ian M Kronish; Kristi Reynolds; Joseph E Schwartz; Daichi Shimbo
Journal:  Hypertension       Date:  2018-11       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.